Nostrum Biodiscovery, a spin-off from the Institute for Research in Biomedicine (IRB Barcelona), a BIST centre, and the Barcelona Supercomputing Center (BSC-CNS), recently received the Senén Vilaró Prize, given to the best innovative company of the year by the “Consejo Social” of the University of Barcelona and the Bosch i Gimpera Foundation.
On December 11th, 2019, the “Consejo Social” of the University of Barcelona and the Bosch i Gimpera Foundation awarded the 2019 Senén Vilaró Prize for best innovative company to Nostrum Biodiscovery, a spin-off from the Institute for Research in Biomedicine (IRB Barcelona) and the Barcelona Supercomputing Center (BSC-CNS).
The award jury acknowledged the cutting-edge technology developed by Nostrum Biodiscovery to accelerate the design of new drugs. The spin-off seeks to help pharmaceutical and biotech companies in the drug discovery process and in enzyme engineering.
Modesto Orozco, IRB Barcelona Group Leader and the company’s Founding Partner, received the prize in the “Premios del Consejo Social y de la Fundación Bosch i Gimpera” ceremony, which was chaired by the Dean of the University of Barcelona (UB), Joan Elias.
Nostrum Biodiscovery was founded in 2016 by Orozco, Head of the Molecular Modelling and Bioinformatics Lab at IRB Barcelona and Senior Professor of the Department of Biochemistry and Molecular Biology at the UB, Víctor Guallar, BSC-CNS Researcher, and Robert Soliva, CSO and Interim CEO of the spin-off, together with their teams at IRB Barcelona and BSC, and with the support of the UB’s Bosch i Gimpera Foundation, the Catalan Institution for Research and Advanced Studies (ICREA) and the Marcelino Botín Foundation.
More information can be found on the IRB Barcelona website.
